October 6, 2020
The FDA has issued an Emergency Use Authorization (EUA) to a clinical decision support (CDS) tool that predicts when an adult patient admitted to the hospital with COVID-19 is at risk of further complications.
Developed by Oakland, California-based diagnostic algorithm developer Dascena, the COViage Hemodynamic Instability and Respiratory Decompensation Prediction System reviews demographic and...
October 6, 2020
A new oncology treatment company dubbed Spesana is emerging out of stealth mode with a new molecular diagnostic decision support tool.
The platform is able to take information from a number of sources and synthesize information for providers. The way it works is Spesana’s tech can collect molecular diagnostic reports and coordinate them with EHRs, prior authorizations, payer processing, approved...
August 3, 2020
Israeli "digital X-ray" startup Nanox filed a Form F-1 with the SEC on Friday that outlines plans to raise $125 million in an IPO.
The company has applied to list its shares on the Nasdaq exchange as "NNOX," and according to a representative has entered its quiet period prior to the IPO.
Nanox, which has raised $110 million from investors since November 2019, is building a two-part offering...
April 24, 2020
About the Author: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug and combination product companies on a wide range of FDA regulatory, reimbursement and clinical trial issues. The opinions in this piece are Thompson's and don't necessarily reflect the opinions of MobiHealthNews or HIMSS.
Many appreciate that telemedicine...
April 20, 2020
As COVID-19 sweeps around the world, we are starting to see countries exit from lockdown, others introducing more stringent lockdown and others relying on the resilience of their health and care systems to allow them to make changes which are more discreet and focused on trying to avoid the economic and political effects of more stringent approaches.
The explosion of data points
Health and care...
March 20, 2020
The FDA announced today a new policy that permits expanded use of connected, non-invasive remote vital sign monitors until the end of the COVID-19 public health emergency.
The agency is relaxing its prior guidance so that healthcare teams can monitor their patients outside of the hospital with certain devices that were previously cleared by the FDA, thereby freeing up space for the high volume...
January 28, 2020
San Francisco-based EHR developer Practice Fusion has agreed to pay $145 million alongside an admission that it “solicited and received kickbacks from a major opioid company” in exchange for clinical decision support (CDS) alerts promoting unnecessary prescription opioids, according to a release from the US Department of Justice.
In a settlement announced yesterday (and hinted at in an earnings...
November 19, 2019
Ada Health is expanding its services in East Africa with a new Swahili language version of its artificial intelligence assessment app.
The tool is pitched as a way for clinicians and patients to get more information about potential symptom causes as well as localized action steps about what to do next.
“The Swahili version of the Ada app can be accessed via smartphone, and offers support to...
November 18, 2019
This morning Biofourmis, maker of an artificial intelligence-enabled monitoring and decision support platform, announced its plans to acquire Zürich, Switzerland-based wearable biosensor company Biovotion. The terms of the deal are not disclosed; however, we do know the deal is made up of a combination of cash and equity.
The acquisition will include Biovotion’s clinical grade-wearable...
October 24, 2019
Healthcare AI company Viz.ai announced that it landed a whopping $50 million in Series B funding this morning. This latest infusion of cash was led by Greenoaks, with participation from Threshold Ventures, CRV, GV and Kleiner Perkins.
The new funding comes a little over a year after the Israeli company raised $21 million from Kleiner Perkins and GV.
WHAT THEY DO
Viz.ai focuses on using AI to...